Medtronic PLC DRC (MDTC34)

B3


	Symbol		Exchange		Currency
	MDTC34		B3		BRL	Delayed
	MDT		NYSE		USD	Real-time
	MDTN		Mexico		MXN	Delayed
	1MDT		Milan		EUR	Real-time
	2M6		Xetra		EUR	Delayed
	2M6		Frankfurt		EUR	Delayed
	2M6		TradeGate		EUR	Delayed
	2M6		Dusseldorf		EUR	Delayed
	MDTm		Buenos Aires		ARS	Delayed
	MDT		Vienna		EUR	Real-time

Currency in BRL

Disclaimer

240.00

0.00(0.00%)

Closed04/10

Fair Value

Day's Range

240.00

240.00

52 wk Range

168.73

254.00

MDTC34 Income Statement

Featured here, the Income Statement (earnings report) for Medtronic PLC DRC, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2015

24/04

2016

29/04

2017

28/04

2018

27/04

2019

26/04

2020

24/04

2021

30/04

2022

29/04

2023

28/04

2024

26/04

Total Revenues

28,913

30,117

31,686

31,227

32,364

Total Revenues Growth

-5.38%

+4.16%

+5.21%

-1.45%

+3.64%

Cost Of Revenues

9,269

10,355

10,028

10,622

11,091

Gross Profit

19,644

19,762

21,658

20,605

21,273

Gross Profit Growth

-8.6%

+0.6%

+9.59%

-4.86%

+3.24%

Gross Profit Margin %

67.94%

65.62%

68.35%

65.98%

65.73%

Other Operating Expenses, Total

14,482

14,272

14,811

14,827

14,864

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-2.04%	-1.45%	+3.78%	+0.11%	+0.25%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	2,331	2,493	2,746	2,696	2,735
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	9,882	9,956	10,047	10,004	10,183
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	513	40	285	429	253

Operating Income

5,162

5,490

6,847

5,778

6,409

Operating Income Growth

-23.06%

+6.35%

+24.72%

-15.61%

+10.92%

EBIT Margin %

17.85%

18.23%

21.61%

18.5%

19.8%

Net Interest Expenses

-1,092

-925

-367

-197

-122

Net Interest Expenses Growth

+24.38%

+15.29%

+60.32%

+46.32%

+38.07%

Interest Expense, Total

-1,092

-925

-553

-583

-719

Interest And Investment Income

-

-

186

386

597

Other Non Operating Expenses, Total

787

110

234

740

-117

EBT, Excl. Unusual Items

4,857

4,675

6,714

6,321

6,170

Gain (Loss) On Sale Of Assets

-

-

-

-75

-

Other Unusual Items, Total

-348

-163

-95

1

-167

EBT, Incl. Unusual Items

4,055

3,895

5,517

5,364

4,837

EBT, Incl. Unusual Items Growth

-21.97%

-3.95%

+41.64%

-2.77%

-9.82%

EBT, Incl. Unusual Items Margin

14.02%

12.93%

17.41%

17.18%

14.95%

Income Tax Expense

-751

265

456

1,580

1,133

Net Income to Company

4,806

3,630

5,061

3,784

3,704

Minority Interest

-17

-24

-22

-26

-28

Net Income

4,789

3,606

5,039

3,758

3,676

Net Income Growth

+3.41%

-24.7%

+39.74%

-25.42%

-2.18%

Net Income Margin %

16.56%

11.97%

15.9%

12.03%

11.36%

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

4,789

3,606

5,039

3,758

3,676

Basic EPS - Continuing Operations

3.57

2.68

3.75

2.83

2.77

Basic EPS - Continuing Operations Growth

+3.85%

-24.94%

+40%

-24.72%

-2.03%

Diluted EPS - Continuing Operations

3.54

2.66

3.73

2.82

2.76

Diluted EPS - Continuing Operations Growth

+3.81%

-24.86%

+40.23%

-24.4%

-2.13%

Basic Weighted Average Shares Outstanding

1,340.7

1,344.9

1,342.4

1,329.8

1,327.7

Diluted Weighted Average Shares Outstanding

1,351.1

1,354

1,351.4

1,332.8

1,330.2

Dividend Per Share

2.16

2.32

2.52

2.72

2.76

Dividend Per Share Growth

+8%

+7.41%

+8.62%

+7.94%

+1.47%

EBITDA

7,825

8,192

9,554

8,475

9,056

EBITDA Growth